greater risk of reduced blood sugar (hypoglycemia) in patients with type 2 diabetes, especially people who also acquire medicines for type two diabetes which include sulfonylureas or insulin. This may be both a significant and customary side outcome. Discuss with your healthcare supplier about how to recognize and handle very low blood sugar and Te